Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Community policy….
View:
Post by Peladawn on Mar 24, 2024 3:12pm

Community policy….

It amazes me how some of these trolls can tell Notable to shut up and quit posting almost every day, and as soon as I suggest maybe they should do the same, my post gets removed.....go figure....Keep posting Notable .....we shareholders appreciate each and every pertinent piece of info you post here every day......
Comment by 13X2413 on Mar 24, 2024 5:38pm
Pertinent? Maybe pertinent a few years ago. 
Comment by Peladawn on Mar 24, 2024 7:07pm
This post has been removed in accordance with Community Policy
Comment by ENEMENEMYNEMO on Mar 24, 2024 7:40pm
Careful now before someone calls you a clown!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities